Patents by Inventor Joost Kreijtz

Joost Kreijtz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-HCTLA-4 antibodies
    Patent number: 10808030
    Abstract: The invention relates to new anti-hCTLA-4 antibodies that bind to a different epitope than prior art anti-CTLA4 antibodies, methods to produce these antibodies and therapeutic and diagnostic uses of these antibodies. These antibodies show a similar affinity for the CTLA4 antigen and they are also able to block the binding of CTLA4 to CD80 and/or CD86.
    Type: Grant
    Filed: October 2, 2017
    Date of Patent: October 20, 2020
    Assignee: ADURO BIOTECH HOLDINGS, EUROPE B.V.
    Inventors: Hans Van Eenennaam, Andrea Van Elsas, Joost Kreijtz, David Lutje Hulsik, Paul Vink
  • Anti-PD-1 antibodies
    Patent number: 10494436
    Abstract: The present invention relates to anti-PD-1 antibodies, as well as use of these antibodies in the treatment of diseases such as cancer and infectious disease. These antibodies have CDRs as provided in the enclosed sequences. Also part of the invention are nucleic acids encoding these antibodies, expression vectors comprising such nucleotide sequences and host cells that comprise said nucleotide sequences or expression vectors.
    Type: Grant
    Filed: July 28, 2017
    Date of Patent: December 3, 2019
    Assignee: ADURO BIOTECH HOLDINGS, EUROPE B.V.
    Inventors: Hans Van Eenennaam, Andrea Van Elsas, Joost Kreijtz, David Lutje Hulsik, Carlos Ricardo Rodrigues Dos Reis
  • NEW ANTI-HCTLA-4 ANTIBODIES
    Publication number: 20180037654
    Abstract: The invention relates to new anti-hCTLA-4 antibodies that bind to a different epitope than prior art anti-CTLA4 antibodies, methods to produce these antibodies and therapeutic and diagnostic uses of these antibodies. These antibodies show a similar affinity for the CTLA4 antigen and they are also able to block the binding of CTLA4 to CD80 and/or CD86.
    Type: Application
    Filed: October 2, 2017
    Publication date: February 8, 2018
    Applicant: ADURO BIOTECH HOLDINGS, EUROPE B.V.
    Inventors: Hans VAN EENENNAAM, Andrea VAN ELSAS, Joost KREIJTZ, David Lutje HULSIK, Paul VINK
  • ANTI-PD-1 ANTIBODIES
    Publication number: 20180030137
    Abstract: The present invention relates to anti-PD-1 antibodies, as well as use of these antibodies in the treatment of diseases such as cancer and infectious disease. These antibodies have CDRs as provided in the enclosed sequences. Also part of the invention are nucleic acids encoding these antibodies, expression vectors comprising such nucleotide sequences and host cells that comprise said nucleotide sequences or expression vectors.
    Type: Application
    Filed: July 28, 2017
    Publication date: February 1, 2018
    Applicant: ADURO BIOTECH HOLDINGS, EUROPE B.V.
    Inventors: Hans VAN EENENNAAM, Andrea VAN ELSAS, Joost KREIJTZ, David Lutje HULSIK, Carlos Ricardo RODRIGUES DOS REIS
  • RECOMBINANT MODIFIED VACCINIA VIRUS ANKARA (MVA)-BASED VACCINE FOR THE AVIAN FLU
    Publication number: 20110020391
    Abstract: The present invention relates to the use of a recombinant modified vaccinia virus Ankara (MVA) comprising a heterologous nucleic acid for the production of a medicament in particular a vaccine, wherein the sequence of heterologous nucleic acid is from influenza A virus class H5 antigen. In a further aspect of the invention the invention relates to a recombinant modified vaccinia virus Ankara (MVA) comprising a heterologous nucleic acid, wherein (a) the heterologous nucleic acid is incorporated into a non-essential site within the genome of MVA, (b) the heterologous nucleic acid is under the control of a vaccinia virus promoter, or orthopoxvirus promoter, or poxvirus-specific promoter and, (c) the heterologous nucleic acid is selected from the group of nucleic acids encoding a gene or a part of a gene from an influenza A virus class H5.
    Type: Application
    Filed: November 16, 2007
    Publication date: January 27, 2011
    Applicant: PAUL-EHRLICH-INSTITUT BUNDESAMT FUR SERA UND IMPFSTOFFE
    Inventors: Yasemin Süzer, Johannes Löwer, Gerd Sutter, A.D.M.E. Osterhaus, G.F Rimmelzwaan, Joost Kreijtz